Christopher Parsons

Christopher Parsons has extensive experience in product development and research and development, with a focus on mass spectrometry-based analysis of tumor biomarker expression assays. Christopher has held director and manager roles at NantOmics, LLC, where they oversaw platform development, managed pharma industry accounts, and identified business development opportunities. Prior to that, they worked at Thermo Fisher Scientific as a project director and project manager, where they managed government-contracted biorepositories and pharmaceutical industry-based projects. Christopher also served as a group leader at Qualyst, Inc., managing operations and logistics and interacting with clients. Christopher began their career as a postdoctoral researcher at the University of North Carolina at Chapel Hill.

Christopher Parsons earned a Bachelor of Science degree in Biochemistry from Case Western Reserve University in 2000. Christopher then pursued their PhD in Biochemistry at the University of North Carolina at Chapel Hill, where they graduated in 2006.